Proteus snaps up $30M to take on heart failure
Proteus Biomedical Inc., a company developing microscopic electromechanical devices capable of one day treating or preventing congestive heart failure, brought in more than $30 million in its first call for fourth round financing. It’s original goal was $28.6 million, but CEO Andrew Thompson says the company is looking for even more money before the round’s second close, VentureWire reported.
The Redwood City, Calif.-based biotech firm is looking to strike out ahead of its competitors, CardioMEMS Inc…. Continue Reading
Life sciences briefing: Wednesday, Jan. 30, 2008
TODAY’S HEADLINES:
Arbor Surgical raises $20M for heart devices (release)
Small Bone Innovations acquires ankle-replacement maker Link America (release)
Active Implants adds $3M for hip and knee implants (VentureWire)
Clarian Health Partners launches VC unit with $25M (release)
Iroko Pharma acquires non-U.S. rights to Merck heart drug (release)
Remmele Engineering acquires medical-device manufacturer EL-Tronic Precision (release)
OpGen appoints former Affymetrix exec Noel Doheny as CEO (release)
Arbor Surgical raises $20M for heart devices – Arbor Surgical, an Irvine, Calif., medical-device maker, raised $20 million… Continue Reading
Life sciences briefing: Monday, Dec. 31, 2007
TODAY’S HEADLINES:
PowerVision pulls in $20M for intraocular lenses (VentureWire)
Heart device maker Mitralign raises $24M (release)
LifeOnKey, electronic medical-record IT firm, draws $5M of $10M round (Globes)
Merrion Pharma withdraws IPO filing (Edgar)
Hi-Tech Pharmacal acquires Midlothian Labs for $5M (release)
Anti-infective developer Calixa receives $15M (VW)
PowerVision pulls in $20M for intraocular lenses — Belmont, Calif.-based PowerVision, a device company developing implantable intraocular lenses, raised $20 million in a second funding round, VentureWire reports. Investors included Advanced Technology Ventures, Frazier… Continue Reading
Life sciences briefing: Wednesday, Dec. 12, 2007
TODAY’S HEADLINES:
Topical Botox maker Revance gets $43M, option to be acquired by Medicis (release)
Reva Medical draws $42M for resorbable stents (release)
AccentCare raises $8M for senior home-care services (VentureWire, sub req’d)
Light Dimensions aims for $6M for light-based skin treatment (VW)
Carigent pulls in $2M for nanoparticle drugs (release)
Celtic Pharma shoots for $1.5B in two drug-investment funds (VW)
Topical Botox developer Revance gets $43M, option to be acquired by Medicis — Mountain View, Calif.-based Revance Therapeutics, a developer of… Continue Reading
Life sciences briefing: Tuesday, Dec. 4, 2007
Featured companies: AgraQuest, BridgeHealth, CardioMems, Collegium Pharmaceutical, Emergin, Entegrion, gDiapers, Precision Therapeutics, PregLem
UPDATED: Expanded items on Entegrion, Collegium, and gDiapers. Added CardioMems item. New items posted on AgraQuest (link), BridgeHealth (link) and Precision Therapeutics (link).
Entegrion draws $4.7M for bleeding control — Entegrion, a Research Triangle Park, N.C., biotech focused on products that stop bleeding, raised $4.7 million in a second funding round, VentureWire reports (subscription req’d). Investors included BD Ventures, Catalysta Partners and unnamed individuals.
Entegrion’s main product… Continue Reading
Life sciences briefing: Monday, Sept. 10, 2007
Featured companies: BioVascular, Carefx, ClinResearch, Healthcare Management Directions, NanoCor, OxyPlus, Revitus, Spotlight Surgical, United BioSource
UPDATED: See below.
Healthcare IT provider Carefx pulls in $17.9M — Carefx, a Scottsdale, Ariz., provider of hardware and software that “aggregates” patient records, has raised $17.85 million in a third funding round, Private Equity Hub reports, citing a regulatory filing. Investors included Carlyle Venture Partners and UV Partners.
Carefx’s pitch is basically the same as that from any system integrator — a term guaranteed… Continue Reading
InnerPulse, abnormal heart rhythms treatment co., raises $50M
InnerPulse, a North Carolina company developing treatments for abnormal heart rhythms, said it has raised $50 million in new equity financing.
The syndicate of investors included Johnson & Johnson Development Corporation, Medtronic, Inc., Synergy Life Science Partners, Ascent Biomedical Ventures, Delphi Ventures and Frazier Heathcare Ventures. Additonally, Boston Scientific and Greatbatch, Inc. remain significant stockholders of InnerPulse, the company said.
From the statement:
The Company’s products employ an innovative technology to simplify the implant utilizing a minimally… Continue Reading